DE69321454D1 - Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit - Google Patents

Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit

Info

Publication number
DE69321454D1
DE69321454D1 DE69321454T DE69321454T DE69321454D1 DE 69321454 D1 DE69321454 D1 DE 69321454D1 DE 69321454 T DE69321454 T DE 69321454T DE 69321454 T DE69321454 T DE 69321454T DE 69321454 D1 DE69321454 D1 DE 69321454D1
Authority
DE
Germany
Prior art keywords
marker
pct
alstonin
cytodiagnostic
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69321454T
Other languages
English (en)
Other versions
DE69321454T2 (de
Inventor
Mirko Beljanski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOLECULAR INTERNATIONAL RESEAR
Original Assignee
MOLECULAR INTERNATIONAL RESEAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOLECULAR INTERNATIONAL RESEAR filed Critical MOLECULAR INTERNATIONAL RESEAR
Application granted granted Critical
Publication of DE69321454D1 publication Critical patent/DE69321454D1/de
Publication of DE69321454T2 publication Critical patent/DE69321454T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/808—Optical sensing apparatus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates
DE69321454T 1992-07-28 1993-07-26 Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit Expired - Fee Related DE69321454T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9209283A FR2694193B1 (fr) 1992-07-28 1992-07-28 Méthode de cytodiagnostic utilisant l'alstonine comme marqueur sélectif et kit de diagnostic contenant ce marqueur.
PCT/FR1993/000762 WO1994002829A1 (fr) 1992-07-28 1993-07-26 Methode de cytodiagnostic utilisant l'alstonine comme marqueur selectif et kit de diagnostic contenant ce marqueur

Publications (2)

Publication Number Publication Date
DE69321454D1 true DE69321454D1 (de) 1998-11-12
DE69321454T2 DE69321454T2 (de) 1999-06-17

Family

ID=9432327

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69321454T Expired - Fee Related DE69321454T2 (de) 1992-07-28 1993-07-26 Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit

Country Status (10)

Country Link
US (1) US5567593A (de)
EP (1) EP0605701B1 (de)
JP (1) JPH07503323A (de)
AT (1) ATE172028T1 (de)
BR (1) BR9305588A (de)
CA (1) CA2120002C (de)
DE (1) DE69321454T2 (de)
ES (1) ES2126652T3 (de)
FR (1) FR2694193B1 (de)
WO (1) WO1994002829A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136540A (en) * 1994-10-03 2000-10-24 Ikonisys Inc. Automated fluorescence in situ hybridization detection of genetic abnormalities
AU1808400A (en) * 1998-10-29 2000-05-22 Merck & Co., Inc. Dihydropyridinones and pyrrolinones useful as alpha 1a adrenoceptor antagonists
JP4536986B2 (ja) * 1999-11-09 2010-09-01 レイセオン カンパニー 腫瘍からの同時多数マーカー放射（ｃａｓｍｍｅｎ）に基づいた細胞解析を行う装置
WO2002074055A2 (en) 2001-03-19 2002-09-26 Ikonisys, Inc. Epifluorecence microscope with improved image contrast
KR20030046063A (ko) * 2001-12-04 2003-06-12 이성문 음식물 찌꺼기와 식물성 찌꺼기를 이용하여 칼슘석회석과(Caco3) 마그네슘(MGO) 장석운모 바이오와재오라이트석 가루를 60매시로 배합하여 숙성시킨칼슘석회질 유기질 비료 제조방법.
WO2006053649A1 (en) * 2004-11-19 2006-05-26 Nowicky Wassili Method for the detection of cancer
WO2006053680A1 (en) * 2004-11-19 2006-05-26 Nowicky Wassili Ex vivo cancer diagnostic method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160018A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Stabilized cancer associated polypeptide antigen and preparation thereof
FR2439783A1 (fr) * 1978-03-13 1980-05-23 Beljanski Mirko Procede d'extraction de la serpentine et de l'alstonine
FR2419725A1 (fr) * 1978-03-13 1979-10-12 Beljanski Mirko Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales
DE3172570D1 (en) * 1981-03-11 1985-11-14 Mirko Beljanski Serpentine, alstonine and sempervirine drugs for the specific inhibition of tumurous and cancerous cells
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
AT387860B (de) * 1985-09-16 1989-03-28 Optical Sensing Technology Verfahren und vorrichtung zur tumordiagnose mittels sera
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents

Also Published As

Publication number Publication date
WO1994002829A1 (fr) 1994-02-03
FR2694193A1 (fr) 1994-02-04
EP0605701B1 (de) 1998-10-07
DE69321454T2 (de) 1999-06-17
US5567593A (en) 1996-10-22
ES2126652T3 (es) 1999-04-01
FR2694193B1 (fr) 1994-10-28
BR9305588A (pt) 1995-05-30
CA2120002C (en) 2007-12-11
CA2120002A1 (en) 1994-02-03
ATE172028T1 (de) 1998-10-15
EP0605701A1 (de) 1994-07-13
JPH07503323A (ja) 1995-04-06

Similar Documents

Publication Publication Date Title
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
DE69307495T2 (de) Oligothionukleotide
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
NO954440D0 (no) 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler
DE69104723T2 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
ATE175201T1 (de) Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
ATE226953T1 (de) 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel und verfahren zu ihrer herstellung
DE69808274T2 (de) Kombinationsprodukt, enthaltend eine nukleinsäure und eine substanz, die die extrazellulärematrix desorganisiert, zur verwendung in gentherapie
BR9507140A (pt) Proteina dna vetor célula capaz de expressar uma proteina kit e processo de teste preparado de luciferase e uso de uma luciferase
ATE429450T1 (de) Chimärische dr4 antikörper und ihre verwendung
ATE555086T1 (de) Paraphenylendiaminderivate, die durch kationische radikale substituierte pyrrolidine enthalten, sowie deren verwendung für die färbung von keratinfasern
DE69306212T2 (de) Kardioaktive 17-aryl und 17-heterozyklyl-14 beta-5alpha-Androstane, Androstene und Androstadiene, ein Verfahren zu ihrer Herstellung und pharmazeutische Präperate davon
DE59510042D1 (de) 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz
DE69310602D1 (de) 3',5'-Ditertbutyl-4'-Hydroxyflavone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung mit Antioxidations- und Antivasokonstriktionsaktivität
DE69321454D1 (de) Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit
DE2239936C2 (de) Verfahren zur quantitativen Bestimmung von Peptidase-Enzymkonzentrationen in Homogenaten unter Verwendung von 4-Methoxy-2-naphthylamiden
ATE153342T1 (de) Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
DE59510713D1 (de) N-substituierte 3-azabicyclo(3.2.0)heptan-derivate als neuroleptika
DE59010919D1 (de) N- und O-substituierte Aminophenolderivate, Zwischenprodukte zu deren Herstellung, deren Verwendung als Hydrolasesubstrate, ein entsprechendes Bestimmungsverfahren und hierfür geeignetes diagnostisches Mittel
DE60034672D1 (de) Reporterverbindungen und verfahren zur bestimmung des lipidisierungsstatus einer zelle
DE69711633D1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
DE59409767D1 (de) Pharmazeutische zusammensetzung in form eines kits enthaltend prostaglandin e1
ATE195529T1 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
DE59001431D1 (de) 1-methoxypyrimidinyl-1h-1,2,4-triazol-3-sulfonsaeurenitroanilide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DERZEIT KEIN VERTRETER BESTELLT

8339 Ceased/non-payment of the annual fee